Artículos por temáticas

Characteristics of responders to interventions for Parkinson disease: a scoping systematic review

Baudendistel ST, Earhart GM.

Neurodegener Dis Manag. 2025 Aug;15(4):173-186. doi: 10.1080/17582024.2025.2493465. Epub 2025 Apr 30.

Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative Diseases and Targeted Therapy

Fang M, Zhou Y, He K, Lu Y, Tao F, Huang H.

Mol Neurobiol. 2025 Jul;62(7):8204-8221. doi: 10.1007/s12035-025-04775-y. Epub 2025 Feb 22.

Multi-function of adipose-derived stem cells on gut disorder: from bench to bedside

Zhao J, Xin S, Liu X, Shi W, Wang B, Wang H, Wang Y, Hua R, Li Y, Gao L, Lu X, Xu J.

Stem Cell Res Ther. 2025 Aug 20;16(1):444. doi: 10.1186/s13287-025-04549-2.

Home-based physical symptom management for family caregivers: systematic review and meta-analysis

Schoth DE, Holley S, Johnson M, Stibbs E, Renton K, Harrop E, Liossi C.

BMJ Support Palliat Care. 2025 Aug 26;15(5):586-599. doi: 10.1136/spcare-2024-005246.

Rectal Administration of Carbidopa/Levodopa

Guthrie A, King J, Casey A.

Ochsner J. 2025 Summer;25(2):114-115. doi: 10.31486/toj.24.0103.

Diagnosis accuracy of touchscreen-based testings for major neurocognitive disorders: a systematic review and meta-analysis

Um Din N, Maronnat F, Zolnowski-Kolp V, Otmane S, Belmin J.

Age Ageing. 2025 Jul 1;54(7):afaf204. doi: 10.1093/ageing/afaf204.

MEDICATION EXPOSURE AND NEURODEGENERATIVE DISEASE RISK ACROSS NATIONAL BIOBANKS

Levine KS, Sargent L, Somerville EN, Pitz V, Price ET, Bandres-Ciga S, Simmonds E, Long RA, Jonson C, Lange LM, Noyce AJ, Escott-Price V, Iwaki H, Keuren-Jensen KV, Ferrucci L, Cookson MR, Singleton A

medRxiv [Preprint]. 2025 Jul 7:2025.07.07.25330740. doi: 10.1101/2025.07.07.25330740.

Doxycycline: An essential tool for Alzheimer's disease

Forloni G.

Biomed Pharmacother. 2025 Jul;188:118159. doi: 10.1016/j.biopha.2025.118159. Epub 2025 May 13.

Robotic arm vs. stereotactic frame in deep brain stimulation surgery for movement disorders: a retrospective cohort study

Perera D, Ramos PR, Valldeoriola F, Sánchez-Gómez A, Ferrés A, Pérez-Baldioceda C, Cabrera G, Mosteiro A, Gómez L, Codes M, Manfrelloti R, Rumià J.

Acta Neurochir (Wien). 2025 Aug 12;167(1):219. doi: 10.1007/s00701-025-06618-0.

Cognitive Decline in Chronic Inflammatory Conditions: Exploring Links Between Systemic Inflammation and Neurodegeneration

Jaramillo Ramos JJ, Galindo Pupo NM, Mena D, Solis RP, Bedoya Jaramillo JE, Vega Solano M.

Cureus. 2025 Jul 21;17(7):e88397. doi: 10.7759/cureus.88397. eCollection 2025 Jul.

Dysphagia Symptoms Contribute to Greater Care Partner Burden in Neurodegenerative Disease

Tabor Gray L, Shune S, Perry S, Kosty D, Namasivayam-MacDonald A.

Am J Speech Lang Pathol. 2025 Jul 10;34(4):2053-2061. doi: 10.1044/2025_AJSLP-24-00529. Epub 2025 May 5.

Δ133p53α-mediated inhibition of astrocyte senescence and neurotoxicity as a possible therapeutic approach for neurodegenerative diseases

Horikawa I, Yamada L, Harris BT, Harris CC.

Neuroscience. 2025 Aug 6;580:54-61. doi: 10.1016/j.neuroscience.2025.06.031. Epub 2025 Jun 14.

Demyelination in psychiatric and neurological disorders: Mechanisms, clinical impact, and novel therapeutic strategies

Murayama R, Cai Y, Nakamura H, Hashimoto K.

Neurosci Biobehav Rev. 2025 Jul;174:106209. doi: 10.1016/j.neubiorev.2025.106209. Epub 2025 May 12.

Unveiling genetic architecture of white matter microstructure through unsupervised deep representation learning of fractional anisotropy maps

Zhao X, Xie Z, He W, Koh HY, Fornage M, Zhi D.

medRxiv [Preprint]. 2025 Aug 19:2025.07.04.25330856. doi: 10.1101/2025.07.04.25330856.

Assessing modified olfactory training to prevent cognitive decline in MCI high-risk individuals: a multicentre randomised controlled trial protocol in Beijing tertiary hospitals

Lin CY, Tan Y, Zhao D, Wu D.

BMJ Open. 2025 Aug 13;15(8):e100880. doi: 10.1136/bmjopen-2025-100880.